MTOR and neoplasm: In the current study, we show that the synergistic combination of RAD001 and BEZ235 is not restricted to these two tumor types, but rather inhibits mTOR signaling, cell viability and tumorigenesis broadly in several different cancer lines, representing various lineages and genetic backgrounds.